Company profile: Cardionics
1.1 - Company Overview
Company description
- Provider of auscultation simulation products and services that support classroom education, clinical and telehealth programs in medical institutions and universities worldwide, including the SAM4 Auscultation Manikin, electronic stethoscopes (options for hearing-impaired users), Bionic Hybrid Simulator, SAM Online remote training, and telehealth systems for sharing live physiological sounds.
Products and services
- Bionic Hybrid Simulator (BHS): Wearable simulator for standardized patient training that enhances skill development in clinical settings
- Electronic Stethoscopes: Electronic instruments that amplify and analyze physiological sounds, with models engineered for hearing-impaired users to support accessible auscultation
- SAM4 Auscultation Manikin: Portable manikin for auscultation training featuring a comprehensive sound library, smartphone control, and Bluetooth connectivity for enhanced learning experiences
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cardionics
Jupiter Endovascular
HQ: United States
Website
- Description: Provider of endovascular medical technologies, including the Vertex Pulmonary Embolectomy System to treat acute pulmonary embolism with enhanced control and precision, and Endoportal Control, a platform that enhances catheter interventions by providing stability and control for access to difficult anatomical sites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jupiter Endovascular company profile →
ivWatch
HQ: United States
Website
- Description: Provider of intravenous infiltration detection solutions, including the ivWatch Monitoring System that continuously monitors peripheral IVs to detect infiltrations and extravasations early with real-time notifications to clinicians; SmartTouch single-use sensor and reusable optical fiber sensor for flexible, comfortable, MRI-compatible IV site monitoring; and OEM solutions to embed the technology into patient monitors or infusion pumps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ivWatch company profile →
Valencia Technologies
HQ: United States
Website
- Description: Provider of implantable neuromodulation solutions for urge urinary incontinence, including eCoin, a coin-sized neurostimulator implanted subcutaneously in the lower leg that delivers automatic intermittent tibial nerve stimulation to reduce symptoms, and the eCoin Physician Qualification training program to certify physicians to offer eCoin therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valencia Technologies company profile →
Genetesis
HQ: United States
Website
- Description: Provider of medical imaging leveraging data science and biomagnetism for cardiovascular disease, offering CardioFlux, a non-invasive cardiac imaging system that measures the magnetic fields generated by the heart's electrical activity to assess myocardial ischemia and microvascular function, and the MAGNETO Trial, a multicenter, prospective, observational cohort study evaluating the diagnostic performance of MCG versus standard noninvasive stress testing in emergency department patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genetesis company profile →
Acron Genomics
HQ: United Kingdom
Website
- Description: Provider of novel biotechnology platform development and commercialization in the life sciences, and of the introduction and development of promising new pharmaceutical compounds. U.S. publicly traded (OTC Markets/AGNM).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acron Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cardionics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cardionics
2.2 - Growth funds investing in similar companies to Cardionics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cardionics
4.2 - Public trading comparable groups for Cardionics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →